Chan Eddie, Patel Amit, Heston Warren, Larchian William
Glickman Urological & Kidney Institute, Cleveland Clinic Foundation, Cleveland, OH 44195, USA.
BJU Int. 2009 Nov;104(9):1286-91. doi: 10.1111/j.1464-410X.2009.08577.x. Epub 2009 Apr 16.
Bladder cancer is a common malignancy in the urinary tract. Despite different therapeutic options, recurrence and progression of urothelial carcinoma after treatment is not uncommon. Novel therapeutic options of bladder cancer are urgently needed. The preclinical evaluation of new treatments requires an animal tumour model that mimics the human counterpart. To date, various animal orthotopic bladder cancer models have been described, but the reported rate of tumour 'take' is 30-100%. The establishment of reliable and reproducible animal models remains an ongoing challenge. We review different kinds of mouse models of orthotopic bladder cancer used in urothelial cancer studies, the methods of implantation, and the reported rate of tumour take. Significant progress has been made recently in noninvasive small animal-imaging in tumour models. It is now possible for researchers to investigate the effects of studied agents by monitoring of in vivo tumour growth directly and noninvasively, as well as measuring a wide range of tumour-related variables in small animals. We summarize the recent development in small-animal imaging for tumour detection and quantification.
膀胱癌是泌尿系统常见的恶性肿瘤。尽管有多种治疗选择,但尿路上皮癌治疗后的复发和进展并不罕见。迫切需要新的膀胱癌治疗方案。新治疗方法的临床前评估需要一个能模拟人类情况的动物肿瘤模型。迄今为止,已描述了各种动物原位膀胱癌模型,但报道的肿瘤“接种成功”率为30%-100%。建立可靠且可重复的动物模型仍然是一个持续存在的挑战。我们综述了尿路上皮癌研究中使用的不同类型的原位膀胱癌小鼠模型、植入方法以及报道的肿瘤接种成功率。最近在肿瘤模型的非侵入性小动物成像方面取得了重大进展。研究人员现在可以通过直接和非侵入性地监测体内肿瘤生长,以及测量小动物体内广泛的肿瘤相关变量,来研究受试药物的效果。我们总结了小动物成像在肿瘤检测和定量方面的最新进展。